Study of the Safety and Tolerability of P 321 Ophthalmic Solution in Subjects With Dry Eye Disease

Phase 1 Completed 53 enrolled Parion Sciences

RandomizedParallel-groupQuadruple-blindTreatment

The purpose of this study is to assess the safety and tolerability of P-321 Ophthalmic Solution in subjects with mild to moderate dry eye disease.

Evaluation	Drug	Modality	Dose	Route
Subject	P-321	Unknown	0.0005 %	Other
Subject	P-321	Unknown	0.0015 %	Other
Subject	P-321	Unknown	0.005 %	Other
Subject	P-321	Unknown	0.01 %	Other